Literature DB >> 17403672

Constitutive/hypoxic degradation of HIF-alpha proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein.

Xianguo Kong1, Beatriz Alvarez-Castelao, Zhao Lin, José G Castaño, Jaime Caro.   

Abstract

The transcriptional activator complex HIF-1 plays a key role in the long term adaptation of cells and tissues to their hypoxic microenvironment by stimulating the expression of genes involved in angiogenesis and glycolysis. The expression of the HIF-1 complex is regulated by the levels of its HIF-alpha subunits that are degraded under normoxic conditions by the ubiquitin-proteasome system. Whereas this pathway of HIF-alpha protein degradation has been well characterized, little is known of their turnover during prolonged hypoxic conditions. Herein, we describe a pathway by which HIF-1alpha and HIF-2alpha proteins are constitutively degraded during hypoxia by the proteasome system, although without requirement of prior ubiquitylation. The constitutive/hypoxic degradation of HIF-alpha proteins is independent of the presence of VHL, binding to DNA, or the formation of a transcriptionally active HIF-1 complex. These results are further strengthened by the demonstration that HIF-alpha proteins are directly degraded in a reconstituted in vitro assay by the proteasome. Finally, we demonstrate that the persistent down-regulation of HIF-1alpha during prolonged hypoxia is mainly caused by a decreased production of the protein without change in its degradation rate. This constitutive, ubiquitin-independent proteasomal degradation pathway of HIF-alpha proteins has to be taken into account in understanding the biology as well as in the development of therapeutic interventions of highly hypoxic tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403672     DOI: 10.1074/jbc.M700704200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  A novel microtubule-modulating agent EM011 inhibits angiogenesis by repressing the HIF-1α axis and disrupting cell polarity and migration.

Authors:  Prasanthi Karna; Padmashree C G Rida; Ravi Chakra Turaga; Jinmin Gao; Meenakshi Gupta; Andreas Fritz; Erica Werner; Clayton Yates; Jun Zhou; Ritu Aneja
Journal:  Carcinogenesis       Date:  2012-06-07       Impact factor: 4.944

2.  Targeted genes and interacting proteins of hypoxia inducible factor-1.

Authors:  Wei Liu; Shao-Ming Shen; Xu-Yun Zhao; Guo-Qiang Chen
Journal:  Int J Biochem Mol Biol       Date:  2012-05-31

3.  Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis.

Authors:  Norihiko Takeda; Ellen L O'Dea; Andrew Doedens; Jung-whan Kim; Alexander Weidemann; Christian Stockmann; Masataka Asagiri; M Celeste Simon; Alexander Hoffmann; Randall S Johnson
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

Review 4.  Context-dependent resistance to proteolysis of intrinsically disordered proteins.

Authors:  Marcin J Suskiewicz; Joel L Sussman; Israel Silman; Yosef Shaul
Journal:  Protein Sci       Date:  2011-06-08       Impact factor: 6.725

5.  SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors.

Authors:  Marco Montagner; Elena Enzo; Mattia Forcato; Francesca Zanconato; Anna Parenti; Elena Rampazzo; Giuseppe Basso; Genesio Leo; Antonio Rosato; Silvio Bicciato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Nature       Date:  2012-07-19       Impact factor: 49.962

6.  p53 regulates renal expression of HIF-1{alpha} and pVHL under physiological conditions and after ischemia-reperfusion injury.

Authors:  Timothy A Sutton; Jared Wilkinson; Henry E Mang; Nicole L Knipe; Zoya Plotkin; Maya Hosein; Katelyn Zak; Jeremy Wittenborn; Pierre C Dagher
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-24

Review 7.  Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke.

Authors:  Honglian Shi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

8.  Anthrax lethal toxin inhibits translation of hypoxia-inducible factor 1α and causes decreased tolerance to hypoxic stress.

Authors:  Weiming Ouyang; Chikako Torigoe; Hui Fang; Tao Xie; David M Frucht
Journal:  J Biol Chem       Date:  2013-12-23       Impact factor: 5.157

9.  Changes in HIF-1α, VEGF, NGF and BDNF levels in cerebrospinal fluid and their relationship with cognitive impairment in patients with cerebral infarction.

Authors:  Xian-Jun Ke; Jun-Jian Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

10.  COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70.

Authors:  Bart van de Sluis; Arjan J Groot; Jeroen Vermeulen; Elsken van der Wall; Paul J van Diest; Cisca Wijmenga; Leo W Klomp; Marc Vooijs
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.